Multiple antiviral activities of the antimalarial and anti-hepatitis C drug candidates N-89 and N-251

Kim, 2001, Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes, J. Med. Chem., 44, 2357, 10.1021/jm010026g Sato, 2011, Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol, Parasitol. Int., 60, 270, 10.1016/j.parint.2011.04.001 Sato, 2011, Antimalarial activity of 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol (N-251) and its carboxylic acid derivatives, Parasitol. Int., 60, 488, 10.1016/j.parint.2011.08.017 Ueda, 2013, New preclinical antimalarial drugs potently inhibit hepatitis C virus genotype 1b RNA replication, PLoS One, 8, e72519, 10.1371/journal.pone.0072519 Pawlotsky, 2016, Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens, Gastroenterology, 151, 70, 10.1053/j.gastro.2016.04.003 Ueda, 2017, Evaluation of preclinical antimalarial drugs, which can overcome direct-acting antivirals-resistant hepatitis C viruses, using the viral reporter assay systems, Virus Res., 235, 37, 10.1016/j.virusres.2017.03.015 Ishikawa, 2015, Construction of an infectious molecular clone of Japanese encephalitis virus genotype V and its derivative subgenomic replicon capable omf expressing a foreign gene, Virus Res., 195, 153, 10.1016/j.virusres.2014.10.010 Kato, 2014, Development of a novel dengue-1 virus replicon system expressing secretory Gaussia luciferase for analysis of viral replication and discovery of antiviral drugs, Jpn. J. Infect. Dis., 67, 209, 10.7883/yoken.67.209 Shiota, 2015, Establishment of hepatitis E virus infection-permissive and -non-permissive human hepatoma PLC/PRF/5 subclones, Microbiol. Immunol., 59, 89, 10.1111/1348-0421.12219 Sells, 1987, Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA, Proc. Natl. Acad. Sci. USA, 84, 1005, 10.1073/pnas.84.4.1005 Okumura, 2015, Negative regulation of hepatitis B virus replication by forkhead box protein A in human hepatoma cells, FEBS Lett., 589, 1112, 10.1016/j.febslet.2015.03.022 Ueda, 2011, Plural assay systems derived from different cell lines and hepatitis C virus strains are required for the objective evaluation of anti-hepatitis C virus reagents, Biochem. Biophys. Res. Commun., 409, 663, 10.1016/j.bbrc.2011.05.061 Nishitsuji, 2015, Novel reporter system to monitor early stages of the hepatitis B virus life cycle, Cancer Sci., 106, 1616, 10.1111/cas.12799 Nishitsuji, 2017, Development of a hepatitis B virus reporter system to monitor the early stages of the replication cycle, J. Vis. Exp., 120, e54849 Dansako, 2016, The cyclic GMP-AMP synthetase-STING signaling pathway is required for both the innate immune response against HBV and the suppression of HBV assembly, FEBS J., 283, 144, 10.1111/febs.13563 Mori, 2011, Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system, Virus Res., 157, 61, 10.1016/j.virusres.2011.02.005 Beaucourt, 2014, Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance, Curr. Opin. Virol., 8, 10, 10.1016/j.coviro.2014.04.011 Morita, 2012, Plasmodium falciparum endoplasmic reticulum-resident calcium binding protein is a possible target of synthetic antimalarial endoperoxides, N-89 and N-251, J. Proteome Res., 11, 5704, 10.1021/pr3005315 World Health Organization, World malaria report, 2015.〈http://www.who.int/malaria/publications/world-malaria-report-2015/en/〉. World Health Organization, Global hepatitis report, 2017.〈http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/〉.